Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.36 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL322669 | 0.83 | — | — | |
| SCHEMBL16812084 | 0.82 | PAM (0.47) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 | |
| SCHEMBL3342301 | 0.82 | MGAM (0.46) | ALDH1A1HSD17B10LMNASMN1; SMN2TSHR | |
| SCHEMBL15945454 | 0.82 | MGAM (0.46) | ALDH1A1HSD17B10LMNASMN1; SMN2TSHR | |
| SCHEMBL8669971 | 0.82 | ALDH1A1 (0.43) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 | |
| SCHEMBL9889314 | 0.82 | ALDH1A1 (0.62) | ALDH1A1HSD17B10LMNASMN1; SMN2TSHR | |
| SCHEMBL27556512 | 0.82 | ALDH1A1 (0.43) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 | |
| SCHEMBL16812081 | 0.80 | ALDH1A1 (0.40) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 | |
| Ammonia Solution, Strong SCHEMBL28155621 | 0.80 | ALDH1A1 (0.56) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 | |
| SCHEMBL11208297 | 0.79 | ALDH1A1 (0.52) | ALDH1A1HSD17B10LMNASMN1; SMN2CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002047674-A2 | USE OF INTRACELLULAR CALCIUM CHELATORS (E.G BAPTA-AM) TO INCREASE SURFACTANT SECRETION IN THE LUNGS | THOMAS JEFFERSON UNIVERSITY (US) | 2002-06-20 | — | — | WO | disclosed |
| US-6251942-B1 | TREATING THE MAMMAL TO INCREASE NEUROTRANSMISSION IN BRAIN, WITH A NON-TOXIC, ENHANCING EFFECTIVE AMOUNT OF A CELL MEMBRANE PERMEANT CALCIUM BUFFER CONAINING BIS (O-AMINOPHENOXY)-ETHANE-N,N,N,N-TETRAACETIC ACID COMPOUND | Carlen, Peter Louis (CA) | 2001-06-26 | — | — | US | disclosed |
| EP-1082113-A2 | COMPOSITIONS AND METHODS FOR ALLEVIATING IMPAIRED MENTAL FUNCTION, MEMORY LOSS AND REDUCING RECOVERY TIME IN ANAESTHETIZED MAMMALS | Carlen, Peter Louis (CA) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999061008-A2 | COMPOSITIONS AND METHODS FOR ALLEVIATING IMPAIRED MENTAL FUNCTION, MEMORY LOSS AND REDUCING RECOVERY TIME IN ANAESTHETIZED MAMMALS | CARLEN PETER LOUIS (CA) | 1999-12-02 | — | — | WO | disclosed |
| EP-0668760-A1 | USE OF A CELL MEMBRANE PERMEANT CALCIUM BUFFER FOR REDUCING INJURY OF MAMMALIAN CELLS IN VIVO | CHARLTON, Milton P. (CA) | 1995-08-30 | — | — | EP | disclosed |
| WO-1994008573-A1 | USE OF A CELL MEMBRANE PERMEANT CALCIUM BUFFER FOR REDUCING INJURY OF MAMMALIAN CELLS IN VIVO | CHARLTON MILTON P (CA) | 1994-04-28 | — | — | WO | disclosed |